Skip to main content
TipRanks
Go Ultimate75% OFF

Neurones (0GX2) Share Price & Analysis

1 Followers

0GX2 Stock Chart & Stats

€40.75-€0.55(-1.33%)
At close: 4:30 PM GMT
€36€38€40Aug 24Sep 9Sep 21Oct 7Oct 21Nov 3Nov 16
Day’s Range
EUR 40.75 - EUR 40.75
52-Week Range
EUR 32.45 - EUR 44.85
Previous Close
EUR 41.30
Volume
N/A
Average Volume (3M)
761
Market Cap
EUR 978.73M
Enterprise Value
EUR 631.41M
Total Cash (Recent Filing)
EUR 301.88M
Total Debt (Recent Filing)
EUR 41.30M
Price to Earnings (P/E)
18.0
Beta
0.60
Next Earnings
Mar 10, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
3.44%

Bulls Say, Bears Say

Bulls Say

Steady Revenue And Profit Growth

Sustained revenue expansion across 2020–2025, combined with solid EBIT margins and an improved net margin, indicates durable demand for Neurones’ consulting and IT services. This growth provides a broader base for recurring client work and supports continued investment in specialist capabilities.

Conservative Balance Sheet

Very low leverage and a growing equity base give Neurones meaningful financial resilience. The company has greater capacity to fund hiring, delivery capabilities, and client initiatives internally, while remaining better positioned to absorb operational volatility without material balance-sheet strain.

Strong Capital Efficiency

The improvement in return on equity suggests that Neurones is converting its accumulated capital into earnings more effectively over time. Combined with controlled leverage, this points to productive capital allocation and supports the durability of shareholder returns as the business continues expanding.

Bears Say

Gross-Margin Volatility

Large gross-margin swings make it harder to assess the underlying durability of reported profitability. They may reflect changes in cost mix or classification and create uncertainty about how consistently revenue growth will translate into gross profit, even though EBIT and net margins remain positive.

Uneven Free-Cash-Flow Growth

Neurones generally converts earnings into cash, but recurring year-to-year declines in free-cash-flow growth reduce predictability. Working-capital or reinvestment swings can therefore affect the timing of internally generated funds available for expansion, distributions, or other capital-allocation priorities.

Utilization And Staffing Sensitivity

Because Neurones primarily sells professional services, profitability depends on keeping consultants and technical specialists productively deployed at appropriate prices. Changes in utilization, staffing costs, subcontracting, or project mix can pressure margins and make earnings quality more sensitive to execution.

Neurones News

0GX2 FAQ

What was Neurones’s price range in the past 12 months?
Neurones lowest share price was €32.45 and its highest was €44.85 in the past 12 months.
What is Neurones’s market cap?
Neurones’s market cap is €978.73M.
When is Neurones’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Neurones’s earnings last quarter?
Neurones released its earnings results on Sep 09, 2026. The company reported €1.073 earnings per share for the quarter.
Is Neurones overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Neurones pay dividends?
Neurones pays an annual dividend of €1.4 which represents an annual dividend yield of 3.44%. See more information on Neurones dividends here
What is Neurones’s EPS estimate?
Neurones’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurones have?
Neurones has 23,842,455 shares outstanding.
What happened to Neurones’s price movement after its last earnings report?
Neurones reported an EPS of €1.073 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Neurones?
Currently, no hedge funds are holding shares in GB:0GX2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology